Published in Infect Immun on February 01, 2002
Abandon the mouse research ship? Not just yet! Shock (2014) 2.60
Biodefense-driven murine model of pneumonic melioidosis. Infect Immun (2003) 1.85
Flagella are virulence determinants of Burkholderia pseudomallei. Infect Immun (2003) 1.83
Inflammasome-dependent pyroptosis and IL-18 protect against Burkholderia pseudomallei lung infection while IL-1β is deleterious. PLoS Pathog (2011) 1.68
A genomic survey of positive selection in Burkholderia pseudomallei provides insights into the evolution of accidental virulence. PLoS Pathog (2010) 1.65
Role of inducible nitric oxide synthase and NADPH oxidase in early control of Burkholderia pseudomallei infection in mice. Infect Immun (2006) 1.45
Impaired neutrophil activity and increased susceptibility to bacterial infection in mice lacking glucose-6-phosphatase-beta. J Clin Invest (2007) 1.41
A type IV pilin, PilA, Contributes To Adherence of Burkholderia pseudomallei and virulence in vivo. Infect Immun (2005) 1.34
Immunostimulatory CpG oligodeoxynucleotide confers protection in a murine model of infection with Burkholderia pseudomallei. Infect Immun (2004) 1.34
MyD88 dependent signaling contributes to protective host defense against Burkholderia pseudomallei. PLoS One (2008) 1.33
Comparative genomics and an insect model rapidly identify novel virulence genes of Burkholderia mallei. J Bacteriol (2008) 1.27
Route of infection in melioidosis. Emerg Infect Dis (2005) 1.25
Inhalation of Burkholderia thailandensis results in lethal necrotizing pneumonia in mice: a surrogate model for pneumonic melioidosis. Trans R Soc Trop Med Hyg (2008) 1.20
Glycogen synthase kinase-3beta (GSK3beta) inhibition suppresses the inflammatory response to Francisella infection and protects against tularemia in mice. Mol Immunol (2008) 1.11
Development of vaccines against burkholderia pseudomallei. Front Microbiol (2011) 1.10
Pathogenicity of high-dose enteral inoculation of Burkholderia pseudomallei to mice. Am J Trop Med Hyg (2010) 1.09
Development of Burkholderia mallei and pseudomallei vaccines. Front Cell Infect Microbiol (2013) 1.08
Regulation of type VI secretion system during Burkholderia pseudomallei infection. Infect Immun (2011) 1.07
Protection against heterologous Burkholderia pseudomallei strains by dendritic cell immunization. Infect Immun (2006) 1.07
Glutathione deficiency in type 2 diabetes impairs cytokine responses and control of intracellular bacteria. J Clin Invest (2012) 1.06
Development of an acute model of inhalational melioidosis in the common marmoset (Callithrix jacchus). Int J Exp Pathol (2011) 1.05
Low-dose exposure of C57BL/6 mice to burkholderia pseudomallei mimics chronic human melioidosis. Am J Pathol (2011) 1.05
Caspase-1 mediates resistance in murine melioidosis. Infect Immun (2009) 1.04
Murine pulmonary infection and inflammation induced by inhalation of Burkholderia pseudomallei. Int J Exp Pathol (2012) 1.03
Genome wide transcriptome profiling of a murine acute melioidosis model reveals new insights into how Burkholderia pseudomallei overcomes host innate immunity. BMC Genomics (2010) 1.03
Experimental acute respiratory Burkholderia pseudomallei infection in BALB/c mice. Int J Exp Pathol (2009) 1.02
An objective approach for Burkholderia pseudomallei strain selection as challenge material for medical countermeasures efficacy testing. Front Cell Infect Microbiol (2012) 1.00
Persistent gastric colonization with Burkholderia pseudomallei and dissemination from the gastrointestinal tract following mucosal inoculation of mice. PLoS One (2012) 0.97
Evaluation of surrogate animal models of melioidosis. Front Microbiol (2010) 0.95
Combining vaccination and postexposure CpG therapy provides optimal protection against lethal sepsis in a biodefense model of human melioidosis. J Infect Dis (2011) 0.94
Induction of mouse melioidosis with meningitis by CD11b+ phagocytic cells harboring intracellular B. pseudomallei as a Trojan horse. PLoS Negl Trop Dis (2013) 0.93
Defense Mechanisms of Hepatocytes Against Burkholderia pseudomallei. Front Microbiol (2012) 0.92
The innate interferon gamma response of BALB/c and C57BL/6 mice to in vitro Burkholderia pseudomallei infection. BMC Immunol (2006) 0.91
Distinct roles for nitric oxide in resistant C57BL/6 and susceptible BALB/c mice to control Burkholderia pseudomallei infection. BMC Immunol (2011) 0.90
Modified virulence of antibiotic-induced Burkholderia pseudomallei filaments. Antimicrob Agents Chemother (2005) 0.90
Prophylactic application of CpG oligonucleotides augments the early host response and confers protection in acute melioidosis. PLoS One (2012) 0.89
Consensus on the development of vaccines against naturally acquired melioidosis. Emerg Infect Dis (2015) 0.88
Correlates of immune protection following cutaneous immunization with an attenuated Burkholderia pseudomallei vaccine. Infect Immun (2013) 0.86
Delayed activation of host innate immune pathways in streptozotocin-induced diabetic hosts leads to more severe disease during infection with Burkholderia pseudomallei. Immunology (2012) 0.83
Burkholderia pseudomallei infection of T cells leads to T-cell costimulation partially provided by flagellin. Infect Immun (2008) 0.82
Characterization and analysis of the Burkholderia pseudomallei BsaN virulence regulon. BMC Microbiol (2014) 0.81
Efficacy of post exposure administration of doxycycline in a murine model of inhalational melioidosis. Sci Rep (2013) 0.80
Characterization of the murine macrophage response to infection with virulent and avirulent Burkholderia species. BMC Microbiol (2015) 0.79
Differential Production of Type I IFN Determines the Reciprocal Levels of IL-10 and Proinflammatory Cytokines Produced by C57BL/6 and BALB/c Macrophages. J Immunol (2016) 0.78
Oropharyngeal aspiration of Burkholderia mallei and Burkholderia pseudomallei in BALB/c mice. PLoS One (2014) 0.78
Type three secretion system-mediated escape of Burkholderia pseudomallei into the host cytosol is critical for the activation of NFκB. BMC Microbiol (2014) 0.77
Pathogenesis of percutaneous infection of goats with Burkholderia pseudomallei: clinical, pathologic, and immunological responses in chronic melioidosis. Int J Exp Pathol (2014) 0.76
In vivo manipulation of γ9(+) T cells in the common marmoset (Callithrix Jacchus) with phosphoantigen and effect on the progression of respiratory melioidosis. PLoS One (2013) 0.76
Burkholderia pseudomallei Capsule Exacerbates Respiratory Melioidosis but Does Not Afford Protection against Antimicrobial Signaling or Bacterial Killing in Human Olfactory Ensheathing Cells. Infect Immun (2016) 0.75
Extended loop region of Hcp1 is critical for the assembly and function of type VI secretion system in Burkholderia pseudomallei. Sci Rep (2015) 0.75
Innate Mucosal Immune System Response of BALB/c vs C57BL/6 Mice to Injury in the Setting of Enteral and Parenteral Feeding. JPEN J Parenter Enteral Nutr (2014) 0.75
HOST IMMUNE RECOGNITION OF THE EPIDEMIC CYSTIC FIBROSIS PATHOGEN BURKHOLDERIA DOLOSA. Infect Immun (2017) 0.75
Involvement of L-selectin expression in Burkholderia pseudomallei-infected monocytes invading the brain during murine melioidosis. Virulence (2016) 0.75
Quantification of murine cytokine mRNAs using real time quantitative reverse transcriptase PCR. Cytokine (1999) 9.70
Melioidosis: a major cause of community-acquired septicemia in northeastern Thailand. J Infect Dis (1989) 8.24
Proposal of Burkholderia gen. nov. and transfer of seven species of the genus Pseudomonas homology group II to the new genus, with the type species Burkholderia cepacia (Palleroni and Holmes 1981) comb. nov. Microbiol Immunol (1992) 6.40
Melioidosis: review and update. Rev Infect Dis (1989) 6.22
Melioidosis: the tip of the iceberg? Clin Microbiol Rev (1991) 5.95
Natural killer cells are a source of interferon gamma that drives differentiation of CD4+ T cell subsets and induces early resistance to Leishmania major in mice. J Exp Med (1993) 4.49
An improved screening technique for isolation of Pseudomonas pseudomallei from clinical specimens. Pathology (1979) 4.01
A T cell-independent mechanism of macrophage activation by interferon-gamma. J Immunol (1987) 3.55
Role of gamma interferon and tumor necrosis factor alpha during T-cell-independent and -dependent phases of Mycobacterium avium infection. Infect Immun (1994) 2.52
Immune responses to Yersinia enterocolitica in susceptible BALB/c and resistant C57BL/6 mice: an essential role for gamma interferon. Infect Immun (1994) 2.45
Interferon gamma, a mediator of lethal lipopolysaccharide-induced Shwartzman-like shock reactions in mice. J Exp Med (1990) 2.25
Serology and carriage of Pseudomonas pseudomallei: a prospective study in 1000 hospitalized children in northeast Thailand. J Infect Dis (1993) 2.20
Interferon gamma receptor deficient mice are resistant to endotoxic shock. J Exp Med (1994) 1.95
The histopathology of human melioidosis. Histopathology (1995) 1.94
BALB/c and C57Bl/6 mice infected with virulent Burkholderia pseudomallei provide contrasting animal models for the acute and chronic forms of human melioidosis. Microb Pathog (1998) 1.76
Characterization of a murine model of melioidosis: comparison of different strains of mice. Infect Immun (1999) 1.75
Endobronchial inflammation following Pseudomonas aeruginosa infection in resistant and susceptible strains of mice. Infect Immun (1995) 1.57
Cytokine gene expression in innately susceptible BALB/c mice and relatively resistant C57BL/6 mice during infection with virulent Burkholderia pseudomallei. Infect Immun (2000) 1.56
Early gamma interferon mRNA expression is associated with resistance of mice against Yersinia enterocolitica. Infect Immun (1994) 1.53
Pathogenesis of and immunity to melioidosis. Acta Trop (2000) 1.38
In vivo induction of interleukin-12 mRNA expression after oral immunization with Salmonella dublin or the B subunit of Escherichia coli heat-labile enterotoxin. Infect Immun (1995) 1.24
Protective role of interferon gamma, tumor necrosis factor alpha and interleukin-6 in Mycobacterium tuberculosis and M. avium infections. Immunobiology (1994) 1.18
Human melioidosis. A histopathologic study of acute and chronic melioidosis. Arch Pathol (1970) 1.15
Macrophage-lymphocyte interactions mediate anti-Burkholderia pseudomallei activity. FEMS Immunol Med Microbiol (1998) 1.05
Antitumour immunity of Bacillus Calmette-Guerin and interferon alpha in murine bladder cancer. Eur J Cancer (1999) 0.97
Caspase-1 dependent macrophage death induced by Burkholderia pseudomallei. Cell Microbiol (2005) 1.62
Characterization of Burkholderia pseudomallei infection and identification of novel virulence factors using a Caenorhabditis elegans host system. Mol Microbiol (2002) 1.58
The Burkholderia pseudomallei BpeAB-OprB efflux pump: expression and impact on quorum sensing and virulence. J Bacteriol (2005) 1.35
The BpsIR quorum-sensing system of Burkholderia pseudomallei. J Bacteriol (2005) 1.27
Recent advances in Blastocystis hominis research: hot spots in terra incognita. Int J Parasitol (2002) 1.16
Suppression of host innate immune response by Burkholderia pseudomallei through the virulence factor TssM. J Immunol (2010) 1.14
Identification of tomato plant as a novel host model for Burkholderia pseudomallei. BMC Microbiol (2010) 1.12
Interleukin-8 induction by Burkholderia pseudomallei can occur without Toll-like receptor signaling but requires a functional type III secretion system. J Infect Dis (2008) 1.11
Regulation of type VI secretion system during Burkholderia pseudomallei infection. Infect Immun (2011) 1.07
Control of quorum sensing by a Burkholderia pseudomallei multidrug efflux pump. J Bacteriol (2007) 1.06
Flagellin contamination of recombinant heat shock protein 70 is responsible for its activity on T cells. J Biol Chem (2006) 1.06
Glutathione deficiency in type 2 diabetes impairs cytokine responses and control of intracellular bacteria. J Clin Invest (2012) 1.06
Detection and differentiation of Burkholderia pseudomallei, Burkholderia mallei and Burkholderia thailandensis by multiplex PCR. FEMS Immunol Med Microbiol (2005) 1.05
CdpA is a Burkholderia pseudomallei cyclic di-GMP phosphodiesterase involved in autoaggregation, flagellum synthesis, motility, biofilm formation, cell invasion, and cytotoxicity. Infect Immun (2010) 1.04
Caspase-1 mediates resistance in murine melioidosis. Infect Immun (2009) 1.04
Unraveling type III secretion systems in the highly versatile Burkholderia pseudomallei. Trends Microbiol (2010) 1.04
Identification of a regulatory cascade controlling Type III Secretion System 3 gene expression in Burkholderia pseudomallei. Mol Microbiol (2010) 1.02
A method for generating marker-less gene deletions in multidrug-resistant Acinetobacter baumannii. BMC Microbiol (2013) 0.93
A role of Burkholderia pseudomallei flagella as a virulent factor. Trans R Soc Trop Med Hyg (2008) 0.92
The innate interferon gamma response of BALB/c and C57BL/6 mice to in vitro Burkholderia pseudomallei infection. BMC Immunol (2006) 0.91
N-Octanoylhomoserine lactone signalling mediated by the BpsI-BpsR quorum sensing system plays a major role in biofilm formation of Burkholderia pseudomallei. Microbiology (2011) 0.91
Modified virulence of antibiotic-induced Burkholderia pseudomallei filaments. Antimicrob Agents Chemother (2005) 0.90
Synergistic interaction between phenothiazines and antimicrobial agents against Burkholderia pseudomallei. Antimicrob Agents Chemother (2006) 0.88
Burkholderia pseudomallei proteins presented by monocyte-derived dendritic cells stimulate human memory T cells in vitro. Infect Immun (2010) 0.88
Burkholderia pseudomallei suppresses Caenorhabditis elegans immunity by specific degradation of a GATA transcription factor. Proc Natl Acad Sci U S A (2013) 0.86
Disruption of biofilm formation by the human pathogen Acinetobacter baumannii using engineered quorum-quenching lactonases. Antimicrob Agents Chemother (2013) 0.85
Growth-related changes in intracellular spermidine and its effect on efflux pump expression and quorum sensing in Burkholderia pseudomallei. Microbiology (2009) 0.84
Mycobacterial heat shock protein 65 enhances antigen cross-presentation in dendritic cells independent of Toll-like receptor 4 signaling. J Leukoc Biol (2003) 0.84
A multigene family of Heteractis magnificalysins (HMgs). Toxicon (2008) 0.84
Burkholderia pseudomallei infection of T cells leads to T-cell costimulation partially provided by flagellin. Infect Immun (2008) 0.82
Assessment of the effect of efflux pump inhibitors on in vitro antimicrobial susceptibility of multidrug-resistant Acinetobacter baumannii. Int J Antimicrob Agents (2013) 0.82
Cloning and molecular characterization of the first aquatic hyaluronidase, SFHYA1, from the venom of stonefish (Synanceja horrida). Gene (2004) 0.79
Identification of a novel repetitive DNA element and its use as a molecular marker for strain typing and discrimination of ara- from ara+ Burkholderia pseudomallei isolates. J Med Microbiol (2002) 0.79
Increased but error-prone nonhomologous end joining in immortalized lymphoblastoid cell extracts from adult cancer patients with late radionecrosis. Int J Radiat Oncol Biol Phys (2008) 0.78
Freeze-fracture and cytochemical studies on the in vitro cyst form of reptilian Blastocystis pythoni. J Eukaryot Microbiol (2003) 0.77
Synthesis of cyclic di-nucleotidic acids as potential inhibitors targeting diguanylate cyclase. Bioorg Med Chem (2010) 0.76
A promising new regimen for the treatment of advanced extranodal NK/T cell lymphoma. Acta Oncol (2011) 0.75
Induction of acute graft-versus-host disease by T cells that do not respond to in vitro alloantigen stimulation. Br J Haematol (2004) 0.75